InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.590
+0.390 (32.50%)
At close: Apr 17, 2026, 4:00 PM EDT
1.620
+0.030 (1.89%)
After-hours: Apr 17, 2026, 7:58 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $114.95 million as of April 17, 2026. Its market cap has increased by 68.30% in one year.
Market Cap
114.95M
Enterprise Value
61.45M
1-Year Change
68.30%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $114.95M, a decrease of -67.24%. That is a compound annual growth rate of -12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 114.90M | 67.98% |
| Dec 31, 2025 | 68.40M | -52.96% |
| Dec 31, 2024 | 145.40M | 51.46% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
| Nov 8, 2017 | 350.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 123.80M |
| Cardiff Oncology | 123.06M |
| Cibus | 121.11M |
| PepGen | 117.50M |
| Aardvark Therapeutics | 114.10M |
| Vivani Medical | 113.43M |
| Seer, Inc. | 112.84M |
| Coya Therapeutics | 112.13M |